Allergan Unanimously Rejects Valeant’s Bid

May 12 (Bloomberg) -- Allergan board says the Valeant bid “substantially undervalues” the company and creates significant risks and uncertainties and is not in best interests of the company and shareholders. Tom Keene reports on Bloomberg Television’s “Bloomberg Surveillance.” (Source: Bloomberg)
The Growth of the Action Camera Market
56:38 - Ricoh Imaging's Jim Malcolm, iON Worldwide CEO Giovanni Tomaselli and 360fly CEO Peter Adderton discuss the growth of the action camera market with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Using Virtual Reality to Change the Face of Journalism
  • 360Fly: Pioneers of Spherical Video Market
  • Ricoh: The Future Potential for 360 Degree Cameras